• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    6/4/24 12:54:09 PM ET
    $AEI
    $AGEN
    $ALBT
    $AMRN
    Real Estate
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AEI alert in real time by email

    Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results.

    Core & Main posted quarterly earnings of 49 cents per share, missing market expectations of 52 cents per share. The company's quarterly sales came in at $1.74 billion versus estimates of $1.72 billion, according to data from Benzinga Pro.

    Core & Main shares dipped 11.4% to $49.77 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • MicroAlgo Inc (NASDAQ:MLGO) shares jumped 284% to 5.99 after the company announced that it will jointly establish a micro-consciousness quantum research center with WiMi.
    • Sobr Safe Inc (NASDAQ:SOBR) surged 112% to $0.56 after the company announced SOBRsure device purchases from two new customers.
    • Annexon, Inc. (NASDAQ:ANNX) climbed 40% to $6.44 after the company’s Phase 3 trial of ANX005 met its primary endpoint.
    • WiMi Hologram Cloud Inc – ADR (NASDAQ:WIMI) shares gained 37.3% to $1.18 after the company announced that the company and MicroAlgo will jointly establish a micro-consciousness quantum research center.
    • Core Scientific Inc (NASDAQ:CORZ) shares rose 29% to $6.28. Core Scientific announced the signing of a series of 12-year contracts with CoreWeave, the AI Hyperscaler.
    • Oblong Inc (NASDAQ:OBLG) gained 25% to $0.32 after the company announced that it signed a non-binding letter of intent to acquire Dwellwell Analytics.
    • Captivision Inc (NASDAQ:CAPT) shares climbed 22.7% to $4.16 after dipping 28% on Monday.
    • Marin Software Inc (NASDAQ:MRIN) gained 21.2% to $2.97. Marin Software announced expanded Amazon integration to unlock channel for all advertisers.
    • Moving Image Technologies Inc (NYSE:MITQ) gained 20.2% to $0.67.
    • Alset Inc (NASDAQ:AEI) shares climbed 19.4% to $1.23
    • CareCloud Inc (NASDAQ:CCLD) shares gained 18.2% to $3.54.
    • Saia Inc (NASDAQ:SAIA) shares climbed 12.3% to $452.00 after the company reported an 18% increase in LTL shipments per workday in April.
    • Terawulf Inc (NASDAQ:WULF) gained 12% to $2.30 after the company issued May 2024 production and operations update.
    • SINTX Technologies Inc (NASDAQ:SINT) gained 11.8% to $7.28.
    • Zai Lab Ltd – ADR (NASDAQ:ZLAB) shares rose 9.9% to $19.78.
    • Hillevax Inc (NASDAQ:HLVX) gained 9.7% to $13.60.
    • Agenus Inc (NASDAQ:AGEN) shares rose 9.3% to $18.55.
    • SkyWest Inc (NASDAQ:SKYW) gained 5.6% to $83.87.
    • Forward Air Corp (NASDAQ:FWRD) gained 3.9% to $17.88.

    Losers

    • ENDRA Life Sciences Inc (NASDAQ:NDRA) shares fell 66.4% to $0.073 after the company announced pricing of $8.0 million public offering.
    • Avalon Globocare Corp (NASDAQ:ALBT) shares fell 30.9% to $0.85 after surging 317% on Monday.
    • Equillium Inc (NASDAQ:EQ) fell 25.2% to $1.10 after the company announced topline data from its Phase 2 study of EQ101 in alopecia areata.
    • JIADE Ltd (NASDAQ:JDZG) fell 21.3% to $9.81.
    • Designer Brands Inc (NYSE:DBI) shares fell 20.5% to $8.79 following first-quarter earnings.
    • MingZhu Logistics Holdings Ltd (NASDAQ:YGMZ) shares fell 17.5% to $0.38. MingZhu Logistics Holdings shares jumped 32% on Monday after the company announced an agreement to acquire Oxylus Global.
    • Humacyte Inc (NASDAQ:HUMA) shares declined 17.1% to $6.11.
    • NewGenIvf Group Ltd (NASDAQ:NIVF) shares fell 16.8% to $1.15. On Monday, NewGenIvf signed a non-binding $617.34 million deal for potential reverse merger with pharma company COVIRIX.
    • GCT Semiconductor Holding Inc (NYSE:GCTS) shares declined 14.6% to $3.92
    • CalAmp Corp (NASDAQ:CAMP) shares declined 14% to $0.87. CalAmp recently entered into a restructuring support agreement to take the company private and has voluntarily initiated proceedings under Chapter 11 of the United States Bankruptcy Code.
    • Nuscale Power Corp (NYSE:SMR) shares fell 12.2% to $6.70.
    • Amarin Corporation plc (NASDAQ:AMRN) shares declined 12% to $0.75 after the company announced that it appointed Aaron Berg as President and CEO.
    • Cibus Inc (NASDAQ:CBUS) shares declined 11.4% to $11.76.
    • Ivanhoe Electric Inc (NYSE:IE) shares fell 10% to $9.73.
    • Bath & Body Works Inc (NYSE:BBWI) fell 10.5% to $46.39 after the company reported first-quarter earnings.
    • ICICI Bank Ltd (NYSE:IBN) shares declined 10.4% to $25.38 as Indian stocks moved lower amid early results from India’s general election.
    • Microbot Medical Inc. (NASDAQ:MBOT) shares fell 9.4% to $1.25 after jumping 38% on Monday.
    • Bark Inc (NYSE:BARK) shares declined 9.3% to $1.27 after the company reported downbeat financial results for its fourth quarter and issued FY25 revenue guidance below estimates.
    • HDFC Bank Ltd (NYSE:HDB) declined 9.2% to $55.62 as Indian stocks moved lower amid early results from India’s general election.
    • Hywin Holdings Ltd – ADR (NASDAQ:HYW) shares fell 9% to $0.61 after jumping 91% on Monday.
    • Axos Financial Inc (NYSE:AX) shares fell 8.9% to $47.79 after Short seller Hindenburg Research issued a short report on the stock.
    • Modine Manufacturing Co (NYSE:MOD) shares fell 8.7% to $91.14.
    • Arch Resources Inc (NYSE:ARCH) shares declined 8.4% to $164.81.
    • Dave Inc (NASDAQ:DAVE) fell 7.5% to $35.05. Dave announced an extension of its official partnership with the Drew League, Los Angeles’ premiere Pro-Am basketball league.
    • GameStop Corp (NYSE:GME) shares fell 5.5% to $26.45, pulling back after rallying 21% on Monday.

    Now Read This: Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $AEI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEI
    $AGEN
    $ALBT
    $AMRN

    CompanyDatePrice TargetRatingAnalyst
    Modine Manufacturing Company
    $MOD
    2/18/2026$263.00Buy
    Roth Capital
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Saia Inc.
    $SAIA
    2/11/2026$425.00Positive → Neutral
    Susquehanna
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    Saia Inc.
    $SAIA
    2/10/2026$250.00Equal-Weight → Underweight
    Morgan Stanley
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    Dave Inc.
    $DAVE
    2/9/2026Outperform
    Keefe Bruyette
    More analyst ratings

    $AEI
    $AGEN
    $ALBT
    $AMRN
    SEC Filings

    View All

    SEC Form 6-K filed by JIADE LIMITED

    6-K - JIADE Ltd (0001976908) (Filer)

    2/20/26 4:05:10 PM ET
    $JDZG
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.

    SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/19/26 9:17:28 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Avalon GloboCare Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

    8-K - Avalon GloboCare Corp. (0001630212) (Filer)

    2/19/26 5:00:25 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Mark Lewis bought $9,060 worth of shares (3,000 units at $3.02), increasing direct ownership by 20% to 18,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/19/26 9:00:04 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Large owner Cetus Capital Vi, L.P. bought $4,034,950 worth of shares (225,000 units at $17.93) and sold $5,940,112 worth of shares (272,163 units at $21.83), decreasing direct ownership by 1% to 3,116,546 units (SEC Form 4)

    4 - FORWARD AIR CORP (0000912728) (Issuer)

    2/17/26 9:56:39 PM ET
    $FWRD
    Integrated Freight & Logistics
    Industrials

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on February 16, 2026 (the "Grant Date"), the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase 8,000 shares of the Company's common stock to a newly hired employee of the Company as an inducement material to such employee's entry into employment with the

    2/20/26 4:05:00 PM ET
    $CAMP

    Bath & Body Works Officially Launches in Amazon's U.S. Stores, Expanding Access to Its Iconic Fragrances and Most Loved Products

    COLUMBUS, Ohio, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works today announced its official launch in Amazon's U.S. stores, making it easier than ever for consumers to discover and shop the brand's iconic fragrances and most loved products. Beginning today, consumers in the U.S. can explore a curated selection of Bath & Body Works' iconic body care and home fragrances—including best sellers like Champagne Toast, A Thousand Wishes, Mahogany Teakwood, and Eucalyptus Spearmint—available in a wide range of fan-favorite forms such as fine fragrance mists, body wash, body cream, hand soap, 3-wick and single wick candles, Wallflowers, and more. This launch establishes the first authorized

    2/20/26 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Univest Securities, LLC Announces Closing of $3.0 Million Registered Direct Offering for its Client JIADE LIMITED (NASDAQ: JDZG)

    New York, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $3.0 million for its client JIADE LIMITED (NASDAQ:JDZG)(the "Company" or "JIADE"), a company that specializes in providing one-stop comprehensive education supporting services to adult education institutions. Under the terms of the securities purchase agreement, the Company has agreed to sell to several investors an aggregate of 12,000,000 of the Company's Class A ordinary shares, par value $0.0001 per share (the "Sh

    2/19/26 5:00:00 PM ET
    $JDZG
    Other Consumer Services
    Real Estate

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Modine Manufacturing with a new price target

    Roth Capital initiated coverage of Modine Manufacturing with a rating of Buy and set a new price target of $263.00

    2/18/26 7:54:26 AM ET
    $MOD
    Auto Parts:O.E.M.
    Consumer Discretionary

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Saia downgraded by Susquehanna with a new price target

    Susquehanna downgraded Saia from Positive to Neutral and set a new price target of $425.00

    2/11/26 7:50:53 AM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Vaknin Rachel

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:18 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chairman, President and CEO Gadot Harel

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:22 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by General Manager, CTO Sharon Simon

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:19 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Designer Brands Inc.

    SC 13G/A - Designer Brands Inc. (0001319947) (Subject)

    12/12/24 6:00:14 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by NuScale Power Corporation

    SC 13D/A - NUSCALE POWER Corp (0001822966) (Subject)

    11/27/24 7:35:05 AM ET
    $SMR
    Metal Fabrications
    Industrials

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Leadership Updates

    Live Leadership Updates

    View All

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer

    Appointment Effective February 16, 2026 COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), today announced that Sheamus Toal will join the company as Executive Vice President, Chief Financial Officer and Principal Financial Officer, effective February 16, 2026. Mark Haley, who has served as Interim Principal Financial Officer during the transition period, will return full time to his position as Senior Vice President, Controller and Principal Accounting Officer. Sheamus brings deep financial

    2/11/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $AEI
    $AGEN
    $ALBT
    $AMRN
    Financials

    Live finance-specific insights

    View All

    CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, I

    2/19/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    Bath & Body Works to Report Fourth Quarter and Fiscal 2025 Results on March 4, 2026

    COLUMBUS, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today that it plans to report its fourth quarter and fiscal 2025 financial results before market open on Wednesday, March 4, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company's website at bbwinc.com. Investors and a

    2/18/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

    DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth quarter and full year 2025 financial results and conduct a conference call on Wednesday, February 25, 2026. The Company will issue a press release detailing its fourth quarter and full year 2025 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET. Information on how to participate is as follows. Access to the live call:Via telephone: Dial in within the United States: 888-506-0062International dial in: 973-528-0011Acces

    2/11/26 8:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care